Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease

Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease

The biomarkers of Parkinson’s disease (PD) remain to be investigated. This work aimed to identify blood biomarkers for PD using targeted metabolomics analysis. We quantified the plasma levels of 255 metabolites in 92 PD patients and 60 healthy controls (HC). PD patients were sub-grouped into early (...

Full description

Bibliographic Details
Main Authors: Kuo-Hsuan Chang, Mei-Ling Cheng, Hsiang-Yu Tang, Cheng-Yu Huang, Hsiu-Chuan Wu, Chiung-Mei Chen
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cells
Subjects:
Parkinson’s disease
biomarker
metabolomics
sphingomyelin
phosphatidylethanolamine
phosphatidylcholine
Online Access:https://www.mdpi.com/2073-4409/11/3/395

Internet

https://www.mdpi.com/2073-4409/11/3/395

Similar Items